Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libbs Farmaceutica LtdafiledCriticalLibbs Farmaceutica Ltda
Priority to BR9905674-7ApriorityCriticalpatent/BR9905674A/en
Publication of BR9905674ApublicationCriticalpatent/BR9905674A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
<B>"UMA FORMULAçãO FARMACêUTICA DE LIBERAçãO PROGRAMADA"<D>. A presente invenção se relaciona com formulação farmacêutica para uso oral e o processo de obtenção da mesma. Particularmente, formulação com aplicação no tratamento da dor de intensidade moderada a severa, aguda ou crónica e de etilogia diversa (pós-operatório, traumatismos, fraturas, neoplasias, etc.). Mais especificamente, o invento se relaciona com formulação à base de Cloridrato de Tramadol, analgésico opióide, veiculado em forma multiparticulada de liberação programada, em que cada unidade de dosagem do produto contém 50 mg ou 100 mg da droga.<B> "A PHARMACEUTICAL FORMULATION OF PROGRAMMED RELEASE" <D>. The present invention relates to pharmaceutical formulation for oral use and the process for obtaining it. Particularly, a formulation with application in the treatment of moderate to severe, acute or chronic pain and of different etiology (postoperative, trauma, fractures, neoplasms, etc.). More specifically, the invention relates to a formulation based on Tramadol Hydrochloride, an opioid analgesic, delivered in a multiparticulate programmed release form, in which each dosage unit of the product contains 50 mg or 100 mg of the drug.
BR9905674-7A1999-11-291999-11-29
A programmed-release pharmaceutical formulation
BR9905674A
(en)
PHARMACEUTICAL SALTS OF THE ACTIVE SUBSTANCE TRAMADOL AND AT LEAST ONE SWEETENER, MEDICINES CONTAINING THESE SALTS, THE USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES AND FORMS OF ADMINISTRATION CONTAINING THOSE SALTS. LAW 17164
Calcilytic compounds, pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising them and their use in the preparation of medicaments for treating disease or disorder characterized by abnormal bone or mineral homeostasis
Combinations of opioid/tlr4 antagonist and acetyl-para-aminophenol (apap) for use in the reduction of toll-like receptor 4(tlr4) and cyclooxygenase-2 (cox-2) activity
PHARMACEUTICAL COMPOSITION INCLUDING AN OPIOID ANALGESIC AND A COMPOUND DERIVED FROM 1-PIPERIDINYLPIPERAZINE; ITS USE FOR THE PREVENTION AND / OR TREATMENT OF PAIN AND NOCICEPTION, AND FOR NAUSEAS AND VOMITES, IN OPIOID BASED TREATMENTS FOR THE